Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors
- PMID: 15827312
- DOI: 10.1001/jama.293.14.1737
Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors
Abstract
Context: Elderly persons with chronic kidney disease have substantial risk for cardiovascular mortality, but the relative importance of traditional and novel risk factors is unknown.
Objective: To compare traditional and novel risk factors as predictors of cardiovascular mortality.
Design, setting, and patients: A total of 5808 community-dwelling persons aged 65 years or older living in 4 communities in the United States participated in the Cardiovascular Health Study cohort. Participants were initially recruited from 1989 to June 1990; an additional 687 black participants were recruited in 1992-1993. The average length of follow-up in this longitudinal study was 8.6 years.
Main outcome measures: Cardiovascular mortality among those with and without chronic kidney disease. Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 mL/min per 1.73 m2.
Results: Among the participants, 1249 (22%) had chronic kidney disease at baseline. The cardiovascular mortality risk rate was 32 deaths/1000 person-years among those with chronic kidney disease vs 16/1000 person-years among those without it. In multivariate analyses, diabetes, systolic hypertension, smoking, low physical activity, nonuse of alcohol, and left ventricular hypertrophy were predictors of cardiovascular mortality in persons with chronic kidney disease (all P values <.05). Among the novel risk factors, only log C-reactive protein (P = .05) and log interleukin 6 (P<.001) were associated with the outcome as linear predictors. Traditional risk factors were associated with the largest absolute increases in risks for cardiovascular deaths among persons with chronic kidney disease: for left ventricular hypertrophy, there were 25 deaths per 1000 person-years; current smoking, 20 per 1000 person-years; physical inactivity, 15 per 1000 person-years; systolic hypertension, 14 per 1000 person-years; diabetes, 14 per 1000 person-years; and nonuse of alcohol, 11 per 1000 person-years vs 5 deaths per 1000 person-years for those with increased C-reactive protein and 5 per 1000 person-years for those with increased interleukin 6 levels. A receiver operating characteristic analysis found that traditional risk factors had an area under the curve of 0.73 (95% confidence interval, 0.70-0.77) among those with chronic kidney disease. Adding novel risk factors only increased the area under the curve to 0.74 (95% confidence interval, 0.71-0.78; P for difference = .15).
Conclusions: Traditional cardiovascular risk factors had larger associations with cardiovascular mortality than novel risk factors in elderly persons with chronic kidney disease. Future research should investigate whether aggressive lifestyle intervention in patients with chronic kidney disease can reduce their substantial cardiovascular risk.
Comment in
-
Chronic kidney disease and cardiovascular risk.JAMA. 2005 Aug 17;294(7):791; author reply 791. doi: 10.1001/jama.294.7.791-a. JAMA. 2005. PMID: 16106000 No abstract available.
Similar articles
-
Kidney function as a predictor of noncardiovascular mortality.J Am Soc Nephrol. 2005 Dec;16(12):3728-35. doi: 10.1681/ASN.2005040384. Epub 2005 Oct 26. J Am Soc Nephrol. 2005. PMID: 16251239
-
Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.Kidney Int Suppl. 2008 Dec;(111):S67-70. doi: 10.1038/ki.2008.519. Kidney Int Suppl. 2008. PMID: 19034331
-
Predictors of new-onset kidney disease in a community-based population.JAMA. 2004 Feb 18;291(7):844-50. doi: 10.1001/jama.291.7.844. JAMA. 2004. PMID: 14970063
-
Chronic kidney disease and cardiovascular disease: pathophysiologic links.Nephrol Nurs J. 2007 Jan-Feb;34(1):55-63; quiz 64-5. Nephrol Nurs J. 2007. PMID: 17345692 Review.
-
Increased mortality in chronic kidney disease: a call to action.Am J Med Sci. 2006 Mar;331(3):150-3. doi: 10.1097/00000441-200603000-00007. Am J Med Sci. 2006. PMID: 16538076 Review.
Cited by
-
Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.Clinics (Sao Paulo). 2015 Apr;70(4):301-11. doi: 10.6061/clinics/2015(04)14. Clinics (Sao Paulo). 2015. PMID: 26017799 Free PMC article. Review.
-
Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study).Am J Cardiol. 2012 Dec 15;110(12):1735-41. doi: 10.1016/j.amjcard.2012.07.044. Epub 2012 Sep 14. Am J Cardiol. 2012. PMID: 22980963 Free PMC article.
-
Risk factors of cardiovascular disease among children with chronic kidney disease in Gaza strip.J Cardiovasc Dis Res. 2012 Apr;3(2):91-8. doi: 10.4103/0975-3583.95360. J Cardiovasc Dis Res. 2012. PMID: 22629024 Free PMC article.
-
Chapter 5: Referral to specialists and models of care.Kidney Int Suppl (2011). 2013 Jan;3(1):112-119. doi: 10.1038/kisup.2012.68. Kidney Int Suppl (2011). 2013. PMID: 25599001 Free PMC article. No abstract available.
-
Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.PLoS One. 2015 Jun 16;10(6):e0128994. doi: 10.1371/journal.pone.0128994. eCollection 2015. PLoS One. 2015. PMID: 26079688 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials